Lice Infestations clinical trials
The registry lists 43 studies for Lice Infestations across more than 10 countries. 4 are recruiting or about to start. 42 of them are mainly about Lice Infestations (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-22.
Get an email when these change. Save the Lice Infestations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Dr. Reddy's Laboratories Limited (7) · Taro Pharmaceuticals USA (7) · ParaPRO LLC (6) · Oystershell NV (4) · Medical Entomology Centre (3) · Centers for Disease Control and Prevention (1) · Larada Sciences, Inc. (1) · South Florida Family Health and Research Centers (1)
What is being tested here
Drugs under test in Lice Infestations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 3 Lice Infestations studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (100%) | 3 (100%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 2 (67%) | 2 (67%) |
| 40 | 2 (67%) | 2 (67%) |
| 50 | 2 (67%) | 2 (67%) |
| 65 | 2 (67%) | 2 (67%) |
| 75 | 2 (67%) | 2 (67%) |
| 85 | 2 (67%) | 2 (67%) |
Across all 43 studies, recruiting or not: 40% stop at 75 or younger and 35% at 65; 93% take children; 2% are for women only and 0% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 43 of 43. search them.
- Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin).RecruitingNCT07660354Not applicable1 country
- Efficacy and Safetyof a Medical Device With a Physical Mode of Action (X92001919) Versus Paranix Anti-lice Shampoo.Not yet recruitingNCT07244523Not applicable
- Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® OnceRecruitingNCT048782761 country
- Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice InfestationRecruitingNCT06057506Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice InfestationCompletedNCT05565820Phase 41 country
- Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, ThailandActive, not recruitingNCT06332872Phase 41 country
- Neem Lotion With Combing for LiceCompletedNCT02974088Phase 21 country
- Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis CapitisCompletedNCT05643820Phase 11 country
- A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.Status unknownNCT05378477Not applicable1 country
- A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.CompletedNCT03617926Not applicable1 country
- A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice InfestationCompletedNCT00528021Phase 21 country
- Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy VolunteersCompletedNCT01518699Phase 11 country
- Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice InfestationCompletedNCT02097485Phase 21 country
- A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationCompletedNCT02060903Phase 31 country
- A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice InfestationCompletedNCT02010333Phase 21 country
- Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationCompletedNCT02062060Phase 31 country
- An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice InfestationCompletedNCT01336647Phase 21 country
- Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice InfestationCompletedNCT01907490Phase 2
- Treatment of Pediculosis (Head Lice) in SenegalCompletedNCT03578679Not applicable1 country
- A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%CompletedNCT03257943Phase 11 country
- Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in FilipinosCompletedNCT03286101Phase 21 country
- Pediatric Head Lice Study Product ComparisonCompletedNCT02213055Phase 21 country
- A Pilot Dose Ranging Study of Spinosad Creme RinseCompletedNCT00858481Phase 21 country
- Effectiveness of "No More" Anti-lice Medical Device to Kill Lice and Lice EggsStatus unknownNCT02569580Not applicable1 country
- Cocamide DEA vs Permethrin for Head LiceTerminatedNCT02500524Phase 31 country
- Two Treatment Regimens of Cocamide DEA Lotion for Head LiceTerminatedNCT02499549Phase 2/3
- Efficacy and Safety of Licefreee Spray Against Nix 1% PermethrinCompletedNCT01514513Not applicable1 country
- Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head LiceCompletedNCT00752973Phase 2/31 country
- Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head LiceCompletedNCT00927472Phase 31 country
- Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head LiceCompletedNCT00963508Phase 31 country
- Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head LiceCompletedNCT00927407Phase 11 country
- Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head LiceTerminatedNCT00291057Phase 21 country
- Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head LiceCompletedNCT00244439Phase 31 country
- Efficacy and Safety Study for PIOLIN® ShampooStatus unknownNCT01966965Phase 31 country
- Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice InfestationCompletedNCT01660321Phase 41 country
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head LiceCompletedNCT00545753Phase 31 country
- Ivermectin in the Treatment of Head LiceCompletedNCT00819520Phase 34 countries
- A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme RinseCompletedNCT00857935Phase 21 country
- Control of Head Lice Infestations in Children and AdultsCompletedNCT00731718Not applicable1 country
- A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of AgeCompletedNCT00410709Phase 11 country
- A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.CompletedNCT00381082Phase 2/31 country
- A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis CapitisCompletedNCT00311779Phase 21 country
- Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753Not applicable1 country